October 31, 2024 Endocrinologic and Metabolic Drugs Advisory Committee
Рет қаралды 7,262
Күн бұрынThe Committee will discuss new drug application 210934, for sotagliflozin oral tablet, submitted by Lexicon Pharmaceuticals, Inc., for the proposed indication, as an adjunct to insulin therapy, to improve glycemic control in adults with type 1 diabetes mellitus and chronic kidney disease.
U.S. Food and Drug Administration
Рет қаралды 1,8 М.
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci...
U.S. Food and Drug Administration
Рет қаралды 622
U.S. Food and Drug Administration
Рет қаралды 18 М.
U.S. Food and Drug Administration
Рет қаралды 1,5 М.
U.S. Food and Drug Administration
Рет қаралды 983
U.S. Food and Drug Administration
Рет қаралды 353
U.S. Food and Drug Administration
Рет қаралды 7 М.
U.S. Food and Drug Administration
Рет қаралды 805
FDA D.I.S.C.O. Burst Edition: FDA approval of Ryoncil (remestemcel-L-rknd) for steroid-refractory...
U.S. Food and Drug Administration
Рет қаралды 787
U.S. Food and Drug Administration
Рет қаралды 5 М.